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Genetic screening of school children in Masalli region in Azerbaijan Republic identified 23 
school children with G6PD enzyme activity different deficiency (from 0 up to 60% 
activity). Biochemical studies were done/performed for school children with activity 
efficiency on enzyme preparations from erythrocytes. As to WHO Guidelines, enzymatic 
preparations were related to the following classes: 2nd class – 13 boys, 3rd class – 6 school 
boys, 4th class – 4 of them. DNA molecular analysis, isolated from blood of the index 
patient, was classified as the 2nd class of G6PD enzyme deficiency and has shown the 
substitution of Guanine nucleotide with Adenine in position 1178. As a result of the 
mutation in protein in the position 393, substitution of amino acids Arginine with Histidine 
[G6PD,1178 (G-A) Arg393His] takes place. 
Keywords: G6PD, biochemical polymorphism, enzyme preparation, abnormal variant, 
gene, molecular-genetic analysis, mutation, nucleotide, amino acid. 
 
Introduction 
Glucose-6-phosphate dehydrogenase (G6PD: EC 1.1.1.49) is defined with gene 
high polymorphism. Enzyme has been identified more than 400 biochemical 
variants and one fourth of them differ with endemicity. One part of the G6PD 
enzyme abnormal variants is endemic for the certain ethnic group, and another part 
is specific to another ethnic group. One group of people with enzymatic deficiency 
gets hemolytic crisis from some medicines and another group of people gets from 
beans (favism) with food (Fuji et al., 1984; Xu et al., 1999; Zuo et al., 1999). 
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Biochemical variants are mainly asymptomatic clinically. Big portion of 
biochemical variants results in hemolytic anemias under the influence of 
chemicals. And small portion of variants leads to severe chronic non-sphericytic 
anemia (Huseynova et al., 2019; Aghayeva et al., 2018; Beutler, 1998). 
The G6PD enzyme gene is located on the X chromosome and is transferred from 
heterozygous mother to a son. Since one of the two X-sex chromosomes is 
inactivated in women, the difference is observed in the clinic of heterozygotes. In 
case non-affected enzyme gene becomes inactive, the affected gene mainly appears 
in erythrocytes and the clinic manifestations are the same as in male hemizygote 
patients (Aghayeva et al., 2019; Boytler, 1981; Hirono et al., 1995; Zuo et al., 
1999). 
According to the data of World Health Organization (1997), around 100 million of 
the world population manifests G6PD enzyme deficiency (WHO, 1997; Du et al., 
1988). 
For Azerbaijan Republic population, study of G6PD enzyme deficiency started in 
the 70s of the last century. Studies were satisfied with only enzymatic activity 
studies (Aghayeva et al., 2019; Boytler, 1981). 
The last century 70s’ studies undertaken for Masalli area population revealed 
G6PD enzyme activity deficiency high frequencies (20-23%). Thus, Masalli area 
was not a random choice when starting our studies (Beutler, 1994; Krasnopolskaya 
& Shatskaya, 1987). 
The goal of our studies was to research on G6PD gene molecular genetics and 
G6PD enzyme physic-chemical characteristics for the index patient from pupils 
living in Masalli area chosen from people with abnormal G6PD activities. 
 
Material and Methods 
Material was collected during screening from pupils from Arabkendi, Gullutepe, 
Tekle, Chakhirli, Bedalan towns of Masalli area and pupils of 7-11 grades from 
Masalli downtown. As a result of screening of 276 pupils, we found 23 boys with 
inherited hemizygous type of G6PD enzyme.   
Material collected for biochemical studies was venous blood samples in tubes with 
EDTA anticoagulant (Huseynova et al., 2019; Aghayeva et al., 2018; Beutler, 
1998). 
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G6PD enzyme activity was identified with modified fluorescence method. To make 
the analysis accurate and to identify the inheritance type, we got their parents and 
family members involved into the study. Totally, there were 302 blood samples 
processed (Aghayeva et al., 2019; Beutler, 1998). 
Purification of enzyme preparations and their classification were done according to 
the WHO standardized methods (WHO, 1988; Krasnopolskaya et al., 1977; 
Krasnopolskaya et al., 1985).  
 
Results and Discussion 
As a result of 23 pupils’ screening on G6PD enzyme, different proportion of 
enzyme deficiency (activity 0-60%) was identified. According to the data of World 
Health Organization (WHO) in 1967, G6PD enzyme activity deficiency (based on 
the lack) was divided into 5 classes: the 1st class – chronic non-spherocytic 
anemia; the 2nd class – acute deficiency of the enzyme (lower than 10%); the 3rd 
class – enzyme medium deficiency (activity 10-60%); the 4th class – very mild 
deficiency of the enzyme (60%) and the 5th class – lower range of normal 
enzymatic activity.  
Our studies have revealed enzyme activity which complies with the WHO 2nd, 3rd 
and 4th classes: 13 persons in the 2nd class, 6 boys in the 3rd and 4 pupils in the 
4th classes. 
Results of the genetic screening of G6PD enzyme carried in Masalli area are 
presented in Table 1. 276 male pupils and 24 their family members were checked 
up in five towns. G6PD enzyme phenotypic frequencies and gene frequencies were 
presented. High results were provided for Masalli town school (11.11% and 0.1111 
in d.f.). The lower results were for Arabkendiand Terle town pupils (5.56% and 
0.0555 in d.f.). For the total area enzymatic deficiency frequency was 8,33%, and 
gene frequency was equal to 0.0833.  
G6PD enzyme deficit in Masalli regional center was  classified as 2, 3 and 4 
classes, whereas in Gullutepe and Bedalan towns, only the 2nd class was presented, 
in Arabkendi and Chakhirli - the 3rd class, and in Tekle both the 2nd and 3rd 
classes were found. In Bedalan town, hemizygote inheritance type for the enzyme 
was identified in F.N. index patient’s 24 family members, and 6 different male 
persons were found with hemizygote inheritance type.  
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72 8 11,11 0.1111 2 pupils – class 2  
2 pupils-7 class 3 
4 pupils - class 4 
Gullutepe 
village 
38 4 10.53 0.1053 3 pupils - class 2 
1 pupil -   class 2 
Arabkendi 
village 
42 3 5.56 0.0555 3 pupils - class 3 
Tekle village 54 3 5.56 0.0555 2 pupils - class 2 
1 pupil - class 3 
Chakhirli 
village 
30 2 7.14 0.0714 2 pupils - class 3 
Bedalan 
village 





24 6 25.0 0.2500 6 persons –   class 2 
Complying to the 2nd class requirements, 24 family members of the school pupil 
F.N. (index patient) from Bedalan town were screened, and 6 of them showed acute 
enzyme activity deficit (lower than 10%). 
Table 2 presents physic-chemical characteristics of enzyme preparations made 
from blood samples of F.N. index patient and his six family members with the 
enzyme deficit in Bedalan town of Masalli area.  





























































































Bedalan 6.0-8.0 85-90 21.3-24.5 78.6-80.0 8.0-9.0 Weak low Mild 
anemia 
In enzyme preparations, the PH-optimum bifase variant was noted within the limits 
of the PH-optimum indicator norm (pH 7,5-8,5) 
Electrophoretic mobility showed norm. All samples manifested lower than norm 
indications according to Michaelis-Menten constant (Km) (21.3-24.5 mkm) for G6P 
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substrates. For 2dG6P substrate analogue, there was high utilization range (78,6-
80,0).  
So, Bedalan variant is classified as a variant with enzyme low activity (6.0-9.0% 
from norm), for G6P substrate has low range of Km binding (24.4 mkm), for 2dG6P 
substrate analogue has high utilization degree (up to 80% of G6P substrate), and 
manifests mild anemia. 
Figure 1 presents a schematic picture of X-sex chromosome structure and G6PD 
locus on it (q28). 
 
Figure 1.  Scheme of X-sex chromosome structure and G6PD locus (q28). 
Gene of G6Pdenzyme is located on the long shoulder of X-sex chromosome in 
subtelomer Xq28 site. The gene of the enzyme Q6FD is located in the subtelomer 
Xq28 part of the long shoulder of the X-sex chromosome 
Firstly, cDNA based on mRNA of G6PD enzyme was synthesized by M. Persico in 
1981. In 1986, T.Takizawa created the cDNA library using liver cells cloning. The 
human q6fd enzyme gene has a size of 13 kbas, consisting of 12 exons and 18 
introns. The exons sizes vary from 12 bp up to 236 bp. The intron sizes vary 
between 97 bp and 11 kb. The Promotor part of  the gene plays the role of TATA 
box prior to 20 nucleotide bases starting from the part of 202 position at 
ATTAAAT 51-terminal. In the promotore part, hexonucleotide sequence 
GGGCGGG is repeated 3 times, and complementary to that, CCCGCCC is 
repeated 6 times. These nucleotide sequences are  usually located  on 12 to 400 
nucleotide bases apart from sequence ATTAAAT. GGGCGGG sequence bases are 
located on a distance of 70kbas from 51-terminal of intron 1. Transcription level is 
equilibrated with CAAT nucleotide sequence and is located at the distance of 220 
nucleotide bases at the 51-terminal rich in GC nucleotide sequences. ATTG 
nucleotide sequence is located at the position 411. 
In 1991, Chen studied 20114 bp sequences involving G6PD enzyme gene. Amino 
acid sequences were predicted using the G6PD enzyme gene sequence.  
Fusco et al. (2012) observed Alu repeat gene at non-involved 51-translation part for 
3 times. 12 Alu genes are located in the biggest intron 2. Capellini and Fiorelli 
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(2008) identified that enzyme G6PD consists of 515 amino acid bases (Aghayeva 
et al., 2018; Du et al., 1988; Hirono et al., 1995; Xu et al., 1999; Zuo et al., 1999).  
In blood of F.N. (index patient), mutation of G6PD enzyme gene was identified as 
a result of DNA molecular analysis. Guanine nucleotide substitution with Adenine 
nucleotide was identified in position 1178. Mutation resulted in substitution of 
Arginine amino acid with Histidine amino acid in position 393.  
For the first time, Filosa et al. (1992) found that the substitution of Guanine with 
Adenine nucleotide happens in position 1178, and this new enzyme mutation was 
referred as G6PD Portici. The authors related this new G6PD enzyme mutation to 
the second group according to WHO classification. 
Thus, as a result of genetic screening of pupils in Masalli area, 23 male pupils were 
identified with different G6PD enzyme deficit (in 0-60% range). Complying to 
WHO requirements, the identified enzyme deficiencies were shared into three 
classes as to their biochemical characteristics: 13 pupils –to the 2nd class, 6 pupils 
– to the 3rd class, and 4 pupils – to the 4th class. Complying to the 2nd class 
requirements, 24 family members of the school pupil F.N. (index patient) from 
Bedalan town were screened, and 6 of them showed acute enzyme activity deficit 
(lower than 10%). DNA molecular analysis of G6PD gene obtained from the blood 
sample of F.N. index patient identified substitution of Guanine nucleotide with 
Adenine nucleotide in position 1178. This mutation resulted in the protein with 
Arginine-to-Histidine [G6PD, 1178 (G-A) Arg393His] substitution in the position 
393 [G6PD, 1178 (G-A) Arg393His].  
 
Conclusion  
So, G6PD enzyme deficiency for Masalli area has shown the following values: 
8.33% for phenotypic frequency and 0.0833 (d.f.) for gene frequency. According to 
the WHO requirements, and according to the biochemical characteristics of the 
identified enzyme deficiency, findings were related to three classes: 13 pupils to 
the 2nd class, 6 pupils to the 3rd class, and 4 pupils to the 4th. Molecular analysis 
of G6PD gene identified substitution of Guanine nucleotide with Adenine 
nucleotide in position 1178. As a result of the mutation in protein in the position 
393, there was substitution of amino acids Arginine with Histidine [G6PD, 1178 
(G-A) Arg393His]. 
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